Hersh, E M; Grogan, T M; Funk, C Y; Barbuto, José Alexandre Marzagão 
; Taylor, C W
Fonte: Proceedings of the American Society of Clinical Oncology. Nome do evento: American Society Clinical Oncology. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERSH, E M et al. Imexon reduces the development of human b cell lymphoma (hbl) in scid mice after inoculation of human peripheral blood lymphocytes (hpbl). Proceedings of the American Society of Clinical Oncology. [S.l.]: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 05 nov. 2024. , 1993APA
Hersh, E. M., Grogan, T. M., Funk, C. Y., Barbuto, J. A. M., & Taylor, C. W. (1993). Imexon reduces the development of human b cell lymphoma (hbl) in scid mice after inoculation of human peripheral blood lymphocytes (hpbl). Proceedings of the American Society of Clinical Oncology. Instituto de Ciências Biomédicas, Universidade de São Paulo.NLM
Hersh EM, Grogan TM, Funk CY, Barbuto JAM, Taylor CW. Imexon reduces the development of human b cell lymphoma (hbl) in scid mice after inoculation of human peripheral blood lymphocytes (hpbl). Proceedings of the American Society of Clinical Oncology. 1993 ;12 369.[citado 2024 nov. 05 ]Vancouver
Hersh EM, Grogan TM, Funk CY, Barbuto JAM, Taylor CW. Imexon reduces the development of human b cell lymphoma (hbl) in scid mice after inoculation of human peripheral blood lymphocytes (hpbl). Proceedings of the American Society of Clinical Oncology. 1993 ;12 369.[citado 2024 nov. 05 ]
